chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got booster shot on Wednesday the 20th, came home and was fatigued. Thursday had horrible headache that would not be relieved with tylenol. I took a plane and arrived at 1130 pm. I went to bed shortly after arriving at my daughters house. Friday morning, I was unable to be woken up and my daughter called 911. I was in a coma. I suffered cardiac arrest during a CT to check for clots. I was resuscitated and put on life support. CT scan for clots, strokes, heart attacks were all clear. I was admitted to the C-ICU and on life support, on the ventilator, and was on 3 different medications at max dosage to keep my blood pressure barely surviving. The doctors told my daughter not to expect me to survive because they had no idea why I was suddenly so ill.  A doctor then told my daughter that my kidneys were failing, and my liver was damaged.  I also developed a high fever and had a high white blood cell count. They gave me Vancomycin and another antibiotic, and then the next the day a kidney doctor gave me lasix to flush out all of the excess fluid. I woke up on Saturday not knowing what had happened and was completely terrified and confused. My daughter was allowed into the ICU to see me and keep me calm, thankfully. She explained to me what happened. I am still in the hospital, as they are keeping me for observation and trying to determine if my kidneys will start working properly again.  Prior to this, I have only ever had a kidney infection, and I thought before I might have had the start of a UTI.  I do have chronic high blood pressure as well, a long term side effect from open heart surgery 10 years prior for an aneurysm, but aside from that I am relatively healthy 50 year old.
Headache, Myalgia, Arthralgia, Fever, inj site red, swollen, tingling down arm; body aches, chills, fatigue, lightheadedness Narrative: hx CA+; tingling down arm of inj site, HA, body aches, chills, joint pain, lightheadedness x7 days,
Vaccine expired 1/28/22 and was given 1/31/22. The manufacturer only has data on administering on day 32 or less from transferring to the fridge from freezer.
feeling fatigue; she has swollen lymph nodes in the right axillary area and the right breast; swollen lymph nodes in the right axillary area and the right breast: She noticed at night on 05Jan2021 because it was sore; swollen lymph nodes in the right axillary area and the right breast: She noticed at night on 05Jan2021 because it was sore; had a slightly elevated Hemoglobin; soreness in the left arm where she received injection; This is a spontaneous report from a contactable consumer.  A 33-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK9231) in the left arm via an unspecified route of administration on 29Dec2020 08:00 at single dose for covid-19 immunisation. Medical history included supraventricular tachycardia  from 2015 (It is under control currently. She was diagnosed in 2015 and she had ablation right away). The patient got the flu vaccine which was required by her workplace was Oct2020. She had flu symptoms, sore throat, and a little headache. Concomitant medication included colecalciferol (VITAMIN D) from 2020 and ongoing. The main side effects was soreness in the left arm where she received injection for one to two days. She couldn't lift her arm. Soreness in the left arm started around 17:00 on 29Dec2020. The patient had a physical on Monday (04Jan2021) and everything was perfectly fine. When she did all the blood work and everything was fine. She had a CBC count on Monday (04Jan2021) and the white blood count was normal. She had a slightly elevated Hemoglobin. All other test like calcium and blood sugar were all normal. Swollen lymph nodes in the right axillary area and the right breast: She noticed at night on 05Jan2021 because it was sore. Then on 06Jan2021 when she looked in the mirror she flexed her arm and saw a line around the breast and it was a little swollen. She got the injection in the left arm. She clarified that she has swollen lymph nodes in the right axillary area and the right breast. There is no swelling on the left. The patient stated today (08Jan2021) the swollen lymph nodes and breast is worse. She is feeling fatigue and can't palpate nodes in breast or axillary area. When she lifts her arm there is a line on the right breast. The outcome of Swollen lymph nodes was not recovered; of other events was unknown.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, and concomitant medication. On or about 25-JUN-2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient a series of debilitating neurological issues. On or about July, 13-AUG-2015, the patient was treated by a physician for sudden and worsening pain in his extremities and difficulty moving. The patient was diagnosed with polymyalgia rheumatica, a serious side effect of ZOSTAVAX. Over the course of six additional medical encounters, the patient was treated for his polymyalgia rheumatica, but his healthcare providers were unable to manage his progressive symptoms and pain. Throughout 2016, the patient was treated by the physician on 16 separate medical encounters, in addition to manage his polymyalgia rheumatica, to no avail. The patient was referred to a hematologist for his atypical and uncontrolled presentation of polymyalgia rheumatica. The patient was prescribed a heavy regimen of prednisone, tramadol, allopurinol, and TYLENOL WITH CODEINE for management of his symptoms. As a result of his painful and dystrophic condition, the patient has been significantly limited in his mobility and ability to live independently. The patient is unable to travel because his immune system has become depleted by his disorder. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Upon internal review, polymyalgia rheumatica was determined to be medically significant. Polymyalgia rheumatica and debilitating neurological issues were considered to be disabling. Additional information has been requested.
After receiving both vaccines around 12:23 pm the patient lost consciousness and urinated herself. The patient passed out for approximately  2 minutes. She was placed in a chair and given some water. EMT's arrived when the patient was already conscious; they evaluated her and told her mom that she was fine. Patient left the store shortly after EMT's left.
Client received 0.5 ml dose as booster dose instead of 0.25 ml dose of Moderna on Friday 11/19. Pt denies all symptoms and reports feeling well during following calls on 11/24,11/26, and 12/1.
Pt seen in ER for f/u on 5/13 after receiving pneumococcal vaccine in clinic on 5/12. He reported feeling general malaise, was febrile and had erythema and irritation at injection site. Pt began w/u to r/o cellulitis as cause of reaction, but left before full eval was completed. At f/u visit with MD on 5/15, fever had abated, however, injection site on right upper arm biceps region was still warm red and indurated, no adenopathy and CBC within NL. Pt was given antibiotics for treatment of presumptive cellulitis at injection site vs. injection site reaction from pneumococcal vaccine. Over several weeks, the injection site irritation has resolved with no further sequelae.
collapsed and hit his head and was unconscious; he collapsed and hit his head and was unconscious; numbness and pain in his head; numbness and pain in his head; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 14Jul2021 13:30 (Batch/Lot Number: 187) (at age 69-years-old) as dose 1, single for covid-19 immunisation. Medical history included back pain from an unknown date and unknown if ongoing. Family history included heart attack (father died from this). Concomitant medication included acetylsalicylic acid, caffeine (BAYER BACK & BODY PAIN) for back pain. On 19Jul2021, patient collapsed and hit his head and was unconscious. He continued to experience numbness and pain in his head. His head, half of his head, his forehead and the top of his head is still numb since the fall. 8 days later he checked himself into the hospital with possible stroke or heart attack and recently got out of the hospital. He had no permanent damage as far as walking or talking but it knocked him down. He doesn't remember anything before the fall; he doesn't remember falling or being unconscious; he just remembers waking up on the floor. He didn't go to the hospital for about eight days, but it didn't get better so his children convinced him to go to the hospital. He was admitted on 30Jul2021 and discharged 02Aug2021. Events resulted in emergency room. He has indoor outdoor carpet with concrete and he hit his head on the concrete. He was getting on 03Aug2021, just a little feeling in his right forehead. He does not blame anyone and doesn't know if this is even related to the shot. He wanted Pfizer to know about his experience.   He was scheduled for the 2nd dose of the Pfizer Covid-19 Vaccine on 04Aug2021 and he did not get it for fear that his body would reject it. Patient had all kinds of tests, MRI and a CAT SCAN. When ask for results he states there was a couple of abnormalities but they sent him home anyway. He thinks he should be under care, being monitored, and they should not have sent him home. Outcome of the event hit his head was not recovered, for event numbness in head was recovering and for the remaining events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This is an initial report of a serious adverse event, received on 04Nov2015, for Protein Sciences FLUBLOK. Subject, a 31 year old female received FLUBLOK intramuscular on 03Nov2015. On 03Nov2015, the same day as receiving FLUBLOK at a clinic, (lot # 550653F, expiration date: 14Jan2016), the subject experienced breathing difficulties-anaphylaxis after the administration of the vaccine. The subject received an EPIPEN dose at the clinic and was sent to the emergency room (ER). Per the reporter, the subject was sent home from the ER after 3 1/2 hours and was doing better with some itching and feeling warm all over. On 06Nov2015 additional information received reported that the subject received EPIPEN at the clinic and in the ER. In the ER patient also received intravenous (IV) BENADRYL 50 mg, IV ranitidine 50 mg and IV SOLUMEDROL 125 mg. The subject was sent home with a prescription for EPIEPENS and oral BENADRYL as needed. On 05Nov2015, the subject went back to the clinic and had treatment for continued sensation of itching and being warm and flushed. She received IV BENADRYL 50 mg and IV ranitidine 50 mg and prednisone in a tapering dose. No additional AE information provided by reporter. The events were considered serious due to the subject's report of an emergency room visit. The outcome of the event of breathing difficulties-anaphylaxis was resolved. The outcome for the event of itching and warm all over was not resolved. Laboratory and/or other relevant test results were not reported. Concomitant medications were not reported.
Initial and follow up information has been received from a physician and later from a registered nurse (RN) by phone concerning a 16 year old white male child with a history of bronchitis, laryngotracheobronchitis, ear infection, pneumonia and "wheezes" who on 25-JAN-2008 was vaccinated IM with a first dose of pneumococcal 23v polysaccharide vaccine (lot # 659149/1383U). The physician reported that the patient experienced "pain, redness and soreness" at the injection site. The spot was also hard to touch. In follow up information it was reported that the patient's mother called the doctor's office and reported that on 25-JAN-2008 at PM her child's arm was red, hard, swollen and tender which lasted for several days. The child recovered several days after the injection was given. No further information expected.
This spontaneous report as received from a other health professional refers to a patient of unknown age.  On SEP-2015 the patient was vaccinated with PROQUAD lot # M014301 for prophylaxis.  Other suspect therapies included VARIVAX. Concomitant therapies included sterile diluent (STERILE DILUENT). On SEP-2015 the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to PROQUAD and VARIVAX.
Body aches (muscle pain). Intense headache. Chills/fever. Fatigue. Nausea.
Within an hour of injection he became very weak, achy and nauseous. Within 3 hours he was running a fever. By the next morning he was having severe nose bleeds. In the 4-5 days span he experienced 5-6 very heavy nose bleeds and by day number 4 was mildly jaundice. He had symptoms for 4-5 days. He had unusual fatigue for over a week. He had not been around anyone else sick prior. His brother received vaccine same day and time and had same symptoms but on a much milder level. His brother, age 11 at the time had symptoms for 2 days. He also had nose bleeds but only 2-3 times. No jaundice noticed.
Fever, arthralgias, dizziness, pain at injection site, shortness of breath, chest tightness, headache, fatigue, photophobia
We administered the wrong vaccine to a Pediatric patient (15 month old) we administered  Moderna pink cap product (0.2mL/10) was given instead of the blue cap product (0.25 mL/25).
Headache, Myalgia, FATIGUE Narrative: RECIEVED VACCINE 1/4/2021 0840, DEVELOPED HA BY 1600, HAD FATIGUE, CHILLS, ACHINESS BY 1930. UNABLE TO WORK 1/5/2021 AND S/S RESOLVED BY AM 1/6/2021
Blood blisters all over both lower legs.  No treatment, symptoms were for about 4 days. Seems to be better now.
about 5 mins p/immun given deltoid area where vax given was pale w/reddness around edges & sl raised; ice pack applied-in about 30mins/color returning to area, swelling going down;
1-2 days after vaccination pt c/o vesicle on back and 3 vesicles with redness and around injection site.
At the site of injection, there is a rash 4 to 5 days later/noticed a rash yesterday; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (At the site of injection, there is a rash 4 to 5 days later/noticed a rash yesterday) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced VACCINATION SITE RASH (At the site of injection, there is a rash 4 to 5 days later/noticed a rash yesterday). At the time of the report, VACCINATION SITE RASH (At the site of injection, there is a rash 4 to 5 days later/noticed a rash yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported
The next day after vaccine, I woke up that morning and my joints ached. It hurt in my hands then radiated to my knees and other joints in my body. This lasted strong for 4-5 hrs., then subsided some. I still felt pain in my hands, elbows, and shoulders. The pain comes and goes and it flares up at times, then gets better as I continue moving.
A vaccine administrator gave "Fluarix" to a child meant for adults 18 years and older by mistake. No known adverse events. No adverse event occured.
Pain at injection site similar to pain from bruise lasting for 5 days. Mild headache for a week. Now one week later, still have mild headache, neck pain, and arm has changed to itching, heat and red area at  & surrounding injection site.
This is a serious post marketed study case from a physician who reports a pt required hospitalization for viral pericarditis after receiving FluMist vaccination. The reporter assessed the events to be possibly related to FluMist study vaccine. On 10Dec04, a 23 year old female received FluMist or Placebo and on 27Dec04 developed acute pericarditis with moderate pericardial effusion while participant in an investigator initiated randomized, double-blinded, placebo-controlled, experimental, epidemiological study. The pt developed trouble breathing on 10Dec04 some time after receiving FluMist. She indicated this to be mild on her daily post vaccination report form from 10Dec04 and moderate on 16Dec04 and 17Dec04. The pt reported feeling chest pain 16Dec04 and constant pressure as well as couldn't take a deep breath. She also had a sinus cold. The pt attributed her chest pain to the cold and her 5 cigarette per day smoking. The pt developed a fever of 100.5 degrees F on 25Dec04. On 26Dec04, the pt had 5-6 bouts of diarrhea. The pt went to urgent care and was subsequently referred to the ER. She presented to the ER on 27Dec04 and was hospitalized with general malaise for the past week that had progressed into substernal chest pressure resulting in difficulty breathing. On the same day she presented to the ER, she also had 5-6 bouts of runny stool as well as low grade fever of 100.5 degree range at home every night over an unspecified date. The hospital discharge summary relates a diagnosis of pericardial effusion, possibly secondary to viral pericarditis. Pulmonary embolism was ruled out due to lack of contraceptive use, no recent travel, no calf symptoms, and the insidious onset of symptoms. The pt's elevated white blood cell count, erythrocyte sedimentation rate, and C-reactive protein indicated an inflammatory process. The discharge summary states the pt's clinical presentation is most consistent with acute viral pericarditis. Chest x-ray indicated an enlarged heart border. A bedside echocardiogram showed results consistent with a moderate sized pericardial effusion but no frank tamponade. Cardiac consultation decided to defer pigtail drainage of effusion in light of the pt's stable clinical findings. A repeat echocardiogram on day of discharge continued to demonstrate a moderate effusion but no change in appearance from 27Dec04. The pt was discharged on 29Dec04 with instructions to continue around the clock NSAIDS for two weeks. As of 04Jan05, the pt claims she feels better but that mild physical exertion such as climbing stairs still causes her to feel chest pressure. The pt will follow up with general medicine on 07Jan05 and cardiology on 27Jan05. Additional information has been requested in terms of infectious agent.
INR was 3 one day after getting vaccine.  4 days after getting vaccine INR dropped to 2.  no changes in diet or medication regimen .  the same thing happened with the first dose of this vaccine. INR dropped one full point and I had to increase warfarn dose to get INR back to 3.  goal 2.5 to 3.5.
Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN and METOPROLOL for Diabetes.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.            Treatment information is not provided.
The patient has a history of COPD, CHF, and chronic kidney disease. She was seen in the ED on 5/10 with gradually worsening shortness of breath over the past several days. In the ED, her O2 sats were at 88%; she was placed on 2L supplemental O2 with improvement. A COVID PCR test done in the ED resulted positive. Of note, the patient previously tested positive on 2/28, however had resolution of symptoms in early March. Ultimately, the patient was admitted 5/10/23 - 5/13/23. Discharge diagnoses include acute hypoxic respiratory failure, acute on chronic diastolic heart failure, suspect pneumonia likely hospital-acquired secondary to strep pneumoniae, and COVID-19 infection, among other diagnoses.  Of note, during admission she was able to be weaned off supplemental oxygen.
On Monday Dec-14-2009 received H1N1 vaccine IM @ 1:55 pm. Within 15 - 20 minutes of receiving vaccine felt nauseated and dizzy. Within about another 15 to 20 minutes reported blurry vision. ER physician suggested to tx symptoms with BENADRYL.
This spontaneous report has been received from a nurse practitioner (also reported as nurse prescriber) referring to an adult patient of unknown gender. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On an unknown date, the patient was vaccinated with a dose of pediatric LIQUID PEDVAXHIB (strength, dose, route, antomical location, lot number and expiration date were not provided) for prophylaxis. The reporter asked about when to repeat or provide another 1/2 dose or a full dose (underdose).
Inc T up to 104.6, 2 hrs post immunizations.Pt carried to ER was given "sponge bath" & APAP to dec T. Was D/C'd to home X several hrs later when T dec.
Vaccine administered with no immediate adverse reaction at 11:29am. Vaccine screening questions were completed and resident was not feeling sick and temperature was 98F. At approximately 1:30pm the resident passed away.
Swelling and pain under left armpit, which is currently guessed to be a lymph node. There was also weakness and slight stomach upset the day following the vaccination 1-8-22
About 4-5 hrs after vaccine was given I developed a sore throat and was hoarse for approximately 5 days (2 days of this I had no voice)
Spike in temp; high heart rate; cloudy urine with a strong odor; cloudy urine with a strong odor; This is a spontaneous report from a contactable consumer (patient's parent). A 28-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL 1283) via an unspecified route of administration on the right arm on 19Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included traumatic brain injury in 2009, vegetative state and known allergies: sulfa. Concomitant medication included fluticasone, levetiracetam (KEPPRA), dextromethorphan hydrobromide (DELSYM), probiotics and miralact. On 20Jan2021 05:00 PM, the patient experienced spike in temp, high heart rate; not sure if this was related but cloudy urine with a strong odor. Took a sample to his primary care. Therapeutic measures were taken as a result of the events which included alternating acetaminophen and ibuprofen. The facility where the vaccine was administered was in an outdoor tent (other). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering.
Pt stated that one day post vax he developed generalized rash with intense itching. Pt was treated at local ER with prednisone and Benadryl. Physician stated rash from the flu shot no levoquin. Rash and itching all gone in 24 hours.